109 related articles for article (PubMed ID: 33525948)
1. ILF3-AS1 promotes cell proliferation and inhibits cell apoptosis of breast cancer by binding with miR-4429 to upregulate RAB14.
Zhang X; Xie X; Gao K; Wu X; Chen Y; Yu T
Hum Exp Toxicol; 2021 Jul; 40(7):1183-1193. PubMed ID: 33525948
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
[TBL] [Abstract][Full Text] [Related]
3. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
Yang J; Liang B; Hou S
J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis.
Han S; Song L; Chen Y; Hou M; Wei X; Fan D
Exp Cell Res; 2020 Aug; 393(2):112087. PubMed ID: 32407730
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ILF3-AS1 aggravates papillary thyroid carcinoma progression via regulating the miR-4306/PLAGL2 axis.
Zeng Z; Teng Q; Xiao J
Cancer Cell Int; 2021 Jun; 21(1):322. PubMed ID: 34176471
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ILF3-AS1 Promotes the Progression of Colon Adenocarcinoma Cells Through the miR-619-5p/CAMK1D Axis.
Liu W; Li S
Onco Targets Ther; 2021; 14():1861-1872. PubMed ID: 33737811
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway.
Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2647-2658. PubMed ID: 32196615
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway.
Yan G; Chang Z; Wang C; Gong Z; Xin H; Liu Z
Dig Liver Dis; 2022 Jan; 54(1):125-135. PubMed ID: 34053876
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
Bo C; Li N; He L; Zhang S; An Y
Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
[TBL] [Abstract][Full Text] [Related]
11. A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration.
Zou Q; Zhou E; Xu F; Zhang D; Yi W; Yao J
J Cell Biochem; 2018 Feb; 119(2):2189-2199. PubMed ID: 28857253
[TBL] [Abstract][Full Text] [Related]
12. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated long non-coding RNA ILF3-AS1 indicates poor prognosis of nasopharyngeal carcinoma and promoted cell metastasis.
Yang X; Lin F; Gao F
Int J Biol Markers; 2020 Dec; 35(4):61-70. PubMed ID: 32962500
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rh7 Suppresses Proliferation, Migration and Invasion of NSCLC Cells Through Targeting ILF3-AS1 Mediated miR-212/SMAD1 Axis.
Chen X; Liu W; Liu B
Front Oncol; 2021; 11():656132. PubMed ID: 33996578
[TBL] [Abstract][Full Text] [Related]
15. SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Biochem Biophys Res Commun; 2019 Apr; 511(3):510-517. PubMed ID: 30819403
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
[No Abstract] [Full Text] [Related]
17. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
18. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
[TBL] [Abstract][Full Text] [Related]
20. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
Shen HM; Zhang D; Xiao P; Qu B; Sun YF
Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
